Baron Wealth Management’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
Other funds holding PBYI
ACA
Baron Wealth Management's PBYI Position: Q3 2026 in Review
Baron Wealth Management reduced its Puma Biotechnology (PBYI) stake by 1.8% in Q3 2026, selling an estimated $5.78K and leaving 35,715 shares worth $355K. The position accounts for 0.09% of the portfolio, ranked #170.
Baron Wealth Management first reported a position in PBYI in Q3 2025 and has held it in 5 quarters since. 156 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.
- Baron Wealth Management held 35,715 shares of Puma Biotechnology worth $355K as of Q3 2026.
- Baron Wealth Management sold 657 Puma Biotechnology shares in Q3 2026, an estimated $5.78K.
- Puma Biotechnology made up 0.09% of Baron Wealth Management's portfolio in Q3 2026, its #170 holding.
- Baron Wealth Management first reported a position in Puma Biotechnology in Q3 2025 and has held it in 5 quarters since.
- 156 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.
Based on Baron Wealth Management's 13F filing for Q3 2026, filed 27 Oct 2026.